Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
12.52
+0.38 (3.17%)
At close: Sep 9, 2025, 4:00 PM
12.28
-0.24 (-1.88%)
After-hours: Sep 9, 2025, 6:13 PM EDT

Contineum Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
351378---
Enterprise Value
181164---
Last Close Price
12.5214.65---
PB Ratio
1.891.91---
P/TBV Ratio
2.051.91---
Debt / Equity Ratio
0.030.030.010.150.08
Debt / EBITDA Ratio
--0.03--
Debt / FCF Ratio
--0.03--
Asset Turnover
--0.55--
Quick Ratio
24.3320.5322.836.2618.78
Current Ratio
24.5120.6923.296.4118.99
Return on Equity (ROE)
-29.24%-26.19%27.71%-48.09%-
Return on Assets (ROA)
-20.42%-18.54%11.10%-23.44%-
Return on Capital (ROIC)
-20.88%-19.30%11.79%-25.44%-
Return on Capital Employed (ROCE)
--12.90%--
Earnings Yield
-16.20%-11.19%---
FCF Yield
-13.33%-8.83%---
Buyback Yield / Dilution
-240.41%-469.95%-51.38%-6.35%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q